Skip to content

P200TE US Reference Database Study

Optos P200TE US Reference Database Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05844852
Enrollment
954
Registered
2023-05-06
Start date
2023-03-14
Completion date
2023-09-13
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Eyes

Brief summary

The objective of this study is to collect Optical Coherence Tomography (OCT) data to construct a reference database for the P200TE.

Detailed description

The objective of this study is to collect Optical Coherence Tomography (OCT) data on healthy eyes in order to develop a reference database for the P200TE device in order to determine the reference limits for the P200TE

Interventions

DEVICEP200TE

The P200TE provides OCT imaging including retinatopography and ONH (optic nerve head) scans.

Sponsors

Optos, PLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Subjects 22 years of age or older on the date of informed consent 2. Subjects able to understand the written informed consent and willing to participate as evidenced by signing the informed consent 3. Subjects presenting at the site with normal eyes (Cataracts, LASIK, PRK (photorefractive keratectomy), and peripheral pathology that does not affect the posterior pole region, for example lattice and peripheral drusen, are allowed. 4. BCVA (best corrected visual acuity) 20/40 or better(each eye) 5. Subject is able to comply with the study procedures

Exclusion criteria

1. Subjects unable to tolerate ophthalmic imaging 2. Subject has a condition or is in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study 3. Subject with ocular media not sufficiently clear toobtain acceptable OCT images 4. .History of leukemia, dementia or multiple sclerosis

Design outcomes

Primary

MeasureTime frameDescription
Retinal Thickness1 yearThe full thickness retina grid consists of a 9-sector circular grid pattern centered on the fovea and based on the ETDRS criteria.
GCC Thickness1 yearThe GCC Thickness
RNFL Thickness1 yearThe RNFL thickness
Optic Nerve Head1 yearThe ONH size

Secondary

MeasureTime frameDescription
Adverse Events1 yearNumber of any adverse events associated with the clinical study to ensure device safety.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026